AU755900C - Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects - Google Patents

Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects

Info

Publication number
AU755900C
AU755900C AU31466/99A AU3146699A AU755900C AU 755900 C AU755900 C AU 755900C AU 31466/99 A AU31466/99 A AU 31466/99A AU 3146699 A AU3146699 A AU 3146699A AU 755900 C AU755900 C AU 755900C
Authority
AU
Australia
Prior art keywords
tectorigenin
estrogen
organ
extracts
utilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU31466/99A
Other versions
AU3146699A (en
AU755900B2 (en
Inventor
Volker Christoffel
Hubertus Jarry
Michael Popp
Barbara Spengler
Wolfgang Wuttke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionorica AG
Original Assignee
Bionorica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7861630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU755900(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bionorica AG filed Critical Bionorica AG
Publication of AU3146699A publication Critical patent/AU3146699A/en
Assigned to BIONORICA AG reassignment BIONORICA AG Amend patent request/document other than specification (104) Assignors: BIONORICA ARZNEIMITTEL GMBH
Application granted granted Critical
Publication of AU755900B2 publication Critical patent/AU755900B2/en
Publication of AU755900C publication Critical patent/AU755900C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

The invention relates to the utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament for selectively treating and/or for the prophylaxis of cardiovascular diseases, especially arteriolosclerosis, osteoporosis and climacteric symptoms, for example, for preventing or alleviating hot flashes. Virtually no uterotropic effects are observed when using said abstracts.
AU31466/99A 1998-03-19 1999-03-19 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects Ceased AU755900C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19812204 1998-03-19
DE19812204A DE19812204A1 (en) 1998-03-19 1998-03-19 Use of extracts from Cimicifuga racemosa and Belamcanda sinensis as an estrogen-like organ-selective drug without uterotropic effects
PCT/EP1999/001860 WO1999047149A1 (en) 1998-03-19 1999-03-19 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects

Publications (3)

Publication Number Publication Date
AU3146699A AU3146699A (en) 1999-10-11
AU755900B2 AU755900B2 (en) 2003-01-02
AU755900C true AU755900C (en) 2005-04-21

Family

ID=7861630

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31466/99A Ceased AU755900C (en) 1998-03-19 1999-03-19 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects

Country Status (21)

Country Link
EP (1) EP1064009B2 (en)
JP (2) JP2002506827A (en)
KR (1) KR100623333B1 (en)
CN (2) CN100444867C (en)
AT (1) ATE225182T1 (en)
AU (1) AU755900C (en)
BR (1) BR9908256A (en)
CA (1) CA2321444C (en)
CZ (1) CZ292684B6 (en)
DE (2) DE19812204A1 (en)
DK (1) DK1064009T4 (en)
ES (1) ES2184427T5 (en)
HK (1) HK1035660A1 (en)
HU (1) HU227694B1 (en)
MX (1) MXPA00007986A (en)
PL (1) PL194096B1 (en)
PT (1) PT1064009E (en)
RU (2) RU2228188C2 (en)
SE (1) SE1064009T4 (en)
TR (1) TR200002686T2 (en)
WO (1) WO1999047149A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000302667A (en) * 1999-04-23 2000-10-31 Kobe Tennenbutsu Kagaku Kk Accelerator for ample breasts
CA2414247C (en) * 2000-06-29 2012-11-27 Quick-Med Technologies, Inc. Cosmetic composition and method comprising a hydroxamate mmpi and a triterpenoid glycoside
IL145876A0 (en) 2000-10-17 2002-07-25 Pfizer Prod Inc Methods and kits for improving vascular health
DE10054641A1 (en) * 2000-11-03 2002-05-16 Schaper & Bruemmer Gmbh Use of a preparation of Cimicifuga racemosa
DE10123503A1 (en) * 2001-05-15 2002-11-21 Bionorica Ag Use of Belamcanda chinensis extract, or its active ingredient, for treating sex hormone-dependent urogenital disorders and prostatic hyperplasia
DE10127897B4 (en) * 2001-06-08 2006-04-20 Bionorica Ag Coated tablet with dry plant extracts
DE10146159A1 (en) * 2001-09-19 2003-04-10 Bionorica Ag Use of extracts from Cimicifuga species as an organ-selective drug for the treatment of sex hormone-dependent diseases of the urogenital tract
EP1325681A1 (en) * 2001-12-11 2003-07-09 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health
DE10206390A1 (en) * 2002-02-15 2003-08-28 Bionorica Ag Use of phytoestrogen-containing extracts that selectively modulate the estrogen receptor beta
JP4605984B2 (en) * 2002-12-20 2011-01-05 アサヒビール株式会社 Stress relieving agent
JP4654187B2 (en) * 2003-05-15 2011-03-16 成都迪康▲ヤオ▼物研究所 Isoflavone derivatives of tectorigenin, their preparation, and antiviral agents containing them as active ingredients
EP1591143A1 (en) * 2004-04-26 2005-11-02 Schaper & Brümmer Gmbh & Co. Kg Composition comprising a combination of Calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
EP1588739A1 (en) * 2004-04-23 2005-10-26 Schaper & Brümmer Gmbh & Co. Kg Composition comprising a combination of calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
US7887851B2 (en) 2004-06-07 2011-02-15 Kao Corporation Aromatase activator
CN100381435C (en) * 2005-03-24 2008-04-16 深圳海王药业有限公司 Extractive of general flavone from blackberry lily, preparation method and application in preparing medication
EP1745796A1 (en) 2005-07-19 2007-01-24 Bionorica Research GmbH Compound preparation for treating prostate carcinoma
CN101057854B (en) * 2006-05-31 2010-05-12 南京大学 Application of cycloartane type triterpenoids compound of cimicifuga rhizome for anti-osteoporosis and menopausal syndrome
DE102007044916A1 (en) 2007-09-19 2009-04-23 Bionorica Ag Cosmetic or dermatological composition for topical use
KR100928013B1 (en) * 2008-01-25 2009-11-24 이화여자대학교 산학협력단 Method for improvement in growth of Echinochola crusgalli using Belamcanda chinensis extract and method for remediation of heavy-metal contaminated soil using the method
CN101797265A (en) * 2010-04-09 2010-08-11 中国人民解放军第二军医大学 Application of belamcanda chinensis total isoflavone or isoflavone compounds in preparing medicaments and food for preventing and treating women's disease
WO2013007807A1 (en) 2011-07-12 2013-01-17 Bionorica Se Selected cimicifuga fractions for the treatment of osteoporosis
EP2545932A1 (en) 2011-07-12 2013-01-16 Bionorica Se Selected cimicifuga fractions for treating osteoporosis
EP2620155A1 (en) 2012-01-30 2013-07-31 Bionorica SE Medicine containing Cimicifuga for use in the treatment of sarcopenia and myocardial weakness
CN102525907B (en) * 2012-02-22 2013-06-05 四川省中医药科学院 Tectorigenin sodium sulfonate injection
CN102631363A (en) * 2012-04-11 2012-08-15 李超生 Application of tectoridin in preparing medicine for preventing osteoporosis
WO2013192114A1 (en) * 2012-06-22 2013-12-27 Golden Biotechnology Corporation Methods and compositions for treating arteriosclerotic vascular diseases
US11541093B2 (en) 2012-07-03 2023-01-03 Max Zeller Soehne Ag Pharmacological use of Cimicifuga extract
JP2014091706A (en) * 2012-11-02 2014-05-19 Kao Corp Glp-1 secretion promoter
KR101964841B1 (en) * 2017-03-07 2019-08-07 주식회사 엘지생활건강 Composition for relieving menopausal symptom
KR101965849B1 (en) * 2017-03-07 2019-04-04 주식회사 엘지생활건강 Composition for relieving menopausal symptom comprising Tectorigenin 7-O-xylosylglucoside
TWI761372B (en) * 2017-09-22 2022-04-21 日商東洋新藥股份有限公司 combination
EP3906040A1 (en) 2018-12-31 2021-11-10 Max Zeller Söhne AG Combination of cimicifuga and petasites extracts for anticancer therapy and prophylaxis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6330417A (en) * 1986-07-23 1988-02-09 Tsumura Juntendo Inc Anti-allergic agent
WO1997009056A1 (en) * 1995-09-07 1997-03-13 L'oreal Extract of iridaceae and compositions containing such extract
EA199800393A1 (en) * 1995-10-23 1998-12-24 Займодженетикс, Инк. COMPOSITIONS AND METHODS OF THEIR APPLICATION FOR THE TREATMENT OF DAMAGE OF BONES
JPH09301884A (en) * 1996-05-15 1997-11-25 Ichimaru Pharcos Co Ltd Testosterone 5 alpha-reductase inhibitor containing blackberry lily extract and alpha-hydroxyl acid and its application
JPH107580A (en) * 1996-06-15 1998-01-13 Michio Yoshida Collagenase inhibitor
JP3665848B2 (en) * 1996-09-18 2005-06-29 木村 幸代 Fermented beverage of Himeogi dwarf bulb extract and method for producing the same
DE19652183C1 (en) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Treating oestrogen-dependent tumour with Cimicifuga racemosa extract

Also Published As

Publication number Publication date
CN100444867C (en) 2008-12-24
EP1064009B9 (en) 2003-02-05
SE1064009T5 (en) 2003-04-15
RU2263505C2 (en) 2005-11-10
DK1064009T4 (en) 2008-08-25
CN1293575A (en) 2001-05-02
EP1064009B1 (en) 2002-10-02
HUP0200921A2 (en) 2002-12-28
KR20010040829A (en) 2001-05-15
RU2228188C2 (en) 2004-05-10
DK1064009T3 (en) 2002-11-04
CA2321444A1 (en) 1999-09-23
SE1064009T4 (en) 2008-09-23
JP2010132699A (en) 2010-06-17
AU3146699A (en) 1999-10-11
SE1064009T3 (en) 2003-01-21
PL194096B1 (en) 2007-04-30
DE59902932D1 (en) 2002-11-07
HUP0200921A3 (en) 2004-05-28
CN1509712A (en) 2004-07-07
TR200002686T2 (en) 2000-12-21
DE19812204A1 (en) 1999-11-04
CA2321444C (en) 2012-10-02
KR100623333B1 (en) 2006-12-05
BR9908256A (en) 2000-12-12
ES2184427T5 (en) 2008-12-16
PT1064009E (en) 2003-02-28
MXPA00007986A (en) 2002-08-06
EP1064009A1 (en) 2001-01-03
HU227694B1 (en) 2011-12-28
ES2184427T3 (en) 2003-04-01
JP2002506827A (en) 2002-03-05
EP1064009B2 (en) 2008-07-30
HK1035660A1 (en) 2001-12-07
ATE225182T1 (en) 2002-10-15
CZ292684B6 (en) 2003-11-12
CZ20002810A3 (en) 2000-12-13
PL342486A1 (en) 2001-06-04
WO1999047149A1 (en) 1999-09-23
AU755900B2 (en) 2003-01-02
RU2003137324A (en) 2005-06-10
CN100581541C (en) 2010-01-20

Similar Documents

Publication Publication Date Title
AU755900C (en) Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects
WO2002047706A3 (en) Selective cox-2 inhibition from plant extracts
DK0835120T3 (en) Pharmaceutical compositions containing active ingredients based on herbs, process for preparing compositions
WO2002047708A3 (en) Selective cox-2 inhibition from edible plant extracts
CA2330128A1 (en) Food compositions, compositions for oral cavity and medicinal compositions for preventing or treating periodontosis and method for preventing or treating periodontosis
TR200002770T2 (en) Treatment of estrogen related disorders
WO1997013489A3 (en) Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions
EP0813875A3 (en) Inhibition of abnormal accumulation of extracellular matrices
WO2000010507A3 (en) Use of melanin for inhibition of angiogenesis and macular degeneration
WO2001051043A3 (en) Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
MX2010003726A (en) Composition for treating hepatitis containing an extract of cordia lutea flowers, annona muricata leaves, and curcuma longa roots.
EP0315378A3 (en) Manufacture of medicaments for treating viral skin infections
AU8369198A (en) Method of preparation and pharmaceutical composition of an uncaria water solubleextract
GR3036569T3 (en) Process for extraction of polyphenolic compounds of catechin type from plants, the so obtained extract and its use
NZ523446A (en) (Aminoalkylbenzoyl) benzofuran or benzothiophene, their process of prepation and the compositions comprising them
NO975858D0 (en) Use of an extract of Cimicifuga racemosa
WO2000071140A3 (en) Methods and compositions for modulating immune response and for the treatment of inflammatory disease
DK1331939T3 (en) Murraya koenigii extracts for the treatment of asthma
IL157630A0 (en) Pharmaceutical and cosmetic compositions for the protection of the skin from damages induced by sun radiations
WO2001003683A3 (en) Cardioactive composition comprising l-carnitine and its derivatives and crataegus extracts
WO2001045662A3 (en) Decorative cosmetic preparations
NO992110L (en) Synthesis of benzo [f] quinolines
AU3151799A (en) Use of at least a plant extract of the compositae family, such as the genus bellis
ES2118052A1 (en) Procedure for the preparation of an extract as a base for obtaining medicaments for the treatment of human ailments of viral origin.

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: BIONORICA AG

Free format text: FORMER NAME: BIONORICA ARZNEIMITTEL GMBH

CB Opposition filed

Opponent name: SCHAPER AND BRUMMER GMBH AND CO. KB

CH Opposition withdrawn

Opponent name: SCHAPER AND BRUMMER GMBH AND CO. KB

NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 20040201 TO 20040801 IN WHICH TO PROVIDE SEARCH RESULTS UNDER S45(3) HAS BEEN FILED